Biobanking for intelligent medicine: assessment and evaluation with the SHARE principle
Journal of the American Medical Informatics Association · 01.07.2026 · 33 (7) · 1333-1344
DOI: 10.1093/jamia/ocag052 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Medical Informatics Association, online erschienen am 27.04.2026. Verfasst von Yin Yang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Research Management, West China Hospital, Sichuan University, Chengdu, 610041, China. Hauptthemen laut MEDLINE: Biological Specimen Banks, Artificial Intelligence. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Background
Biobanks are essential for intelligent medicine but face fragmentation and heterogeneity. No standardized framework exists for assessing biobank data value using public information; this study addresses this gap. Materials and Methods We systematically evaluated 94 global biobanks (2010-2024) through a literature review and structured data extraction. Based on 12 international standards, we developed the 5-dimensional SHARE principle (Standardization, Hierarchical structuring, Analytical compatibility, Regulatory compliance, Evolutionary adaptability), operationalized into 10 indicators with a 4-tier scoring system. GPT-4o provided AI-supported prescoring, which was validated by 10 experts and through case studies, including RARPKB.
Results
The SHARE principle and a classification map of 94 biobanks were generated. AI and expert scoring showed substantial consistency (κ = 0.62; 95% CI, 0.54-0.70). Biobanks were categorized into 4 tiers: Traditional (60-69), Data-Driven (70-79), Knowledge-Guided (80-89), and Generative and Reasoning-oriented Biobank (90-100). Case validation confirmed utility for disease-specific biobanks.
Discussion
We highlight the principal findings, critically examine the reliance on public documentation, propose mitigation strategies, and discuss indicator weighting and implications for translational informatics.
Conclusions
The SHARE principle provides a scalable, standardized method for assessing biobank data value, supporting biobank development, resource discovery, and the development of AI-driven biomedical ecosystems for intelligent medicine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical Research Management, West China Hospital, Sichuan University, Chengdu, 610041, China.
- Institutes for Systems Genetics, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, 610041, China.
- Department of Computer Science and Information Technologies, University of A Coruña, Campus Elviña s/n15071, A Coruña, Spain.
ORCID-Profile: Yin Yang, Bairong Shen
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Yang, Y., Ullah, A., Zhang, Y., Zong, H., Liu, X., Zhang, C., Hu, S., Li, J., & Shen, B. (2026). Biobanking for intelligent medicine: assessment and evaluation with the SHARE principle. Journal of the American Medical Informatics Association, 33(7), 1333-1344. https://doi.org/10.1093/jamia/ocag052
Vancouver
Yang Y, Ullah A, Zhang Y, Zong H, Liu X, Zhang C, et al. Biobanking for intelligent medicine: assessment and evaluation with the SHARE principle. Journal of the American Medical Informatics Association. 2026;33(7):1333-1344. doi:10.1093/jamia/ocag052
BibTeX
@article{Yang2026,
author = {Yang, Yin and Ullah, Amin and Zhang, Yingbo and Zong, Hui and Liu, Xingyun and Zhang, Chi and Hu, Shanshan and Li, Jiakun and Shen, Bairong},
title = {Biobanking for intelligent medicine: assessment and evaluation with the SHARE principle},
journal = {Journal of the American Medical Informatics Association},
year = {2026},
volume = {33},
number = {7},
pages = {1333--1344},
doi = {10.1093/jamia/ocag052}
}
EUVIMED